SCHEMBL21929296

SCHEMBL21929296

Cc1ccccc1-c1ccc2c3ccc(-c4ccccc4C)cc3n(-c3cc(-c4ccccc4C#N)c(-n4c5cc(-c6ccccc6C)ccc5c5ccc(-c6ccccc6C)cc54)cn3)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.40
TRPA1 O75762 2/20 0.37
CYP1A2 P05177 5/20 0.36
CYP3A4 P08684 5/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 3/20 0.36
HPGD P15428 3/20 0.36
MAPK1 P28482 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
GABRA1 P14867 4/20 0.36
GABRG2 P18507 4/20 0.36
GABRB3 P28472 4/20 0.36
GABRA2 P47869 4/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
IMPDH2 P12268 1/20 0.36
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
KDM4E B2RXH2 3/20 0.35
NR3C1 P04150 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21931795 0.97 AR (0.38) ARTRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21929297 0.93 AR (0.41) ARTRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21931788 0.92 TRPA1 (0.43) TRPA1CYP1A2CYP3A4ALDH1A1HSD17B10
SCHEMBL24738591 0.92 GABRA1 (0.38) ARTRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21931796 0.92 AR (0.39) ARTRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21929033 0.89 GABRA1 (0.36) ARTRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL24739683 0.89 GABRA1 (0.37) ARTRPA1CYP1A2CYP3A4ALDH1A1
SCHEMBL21931789 0.89 TRPA1 (0.41) TRPA1CYP1A2CYP3A4ALDH1A1HSD17B10
SCHEMBL21929068 0.89 TRPA1 (0.35) TRPA1CYP1A2CYP3A4ALDH1A1HSD17B10
SCHEMBL21928629 0.88 GRIN1 (0.41) TRPA1CYP1A2CYP3A4ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed
EP-3609978-B1 ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-03-17 EP disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 AR 1616/4885TRPA1 121/4885CYP1A2 353/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA AR 2795/4885TRPA1 33/4885CYP1A2 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.